- Home
- BDL vs KZR Comparison
BDL vs KZR Comparison
Compare BDL & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- KZR
- Stock Information
- Founded
- BDL 1959
- KZR 2015
- Country
- BDL United States
- KZR United States
- Employees
- BDL N/A
- KZR N/A
- Industry
- BDL Restaurants
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- BDL Consumer Discretionary
- KZR Health Care
- Exchange
- BDL Nasdaq
- KZR Nasdaq
- Market Cap
- BDL 48.0M
- KZR 44.1M
- IPO Year
- BDL N/A
- KZR 2018
- Fundamental
- Price
- BDL $24.71
- KZR $4.55
- Analyst Decision
- BDL
- KZR Hold
- Analyst Count
- BDL 0
- KZR 2
- Target Price
- BDL N/A
- KZR $9.00
- AVG Volume (30 Days)
- BDL 2.0K
- KZR 22.4K
- Earning Date
- BDL 05-13-2025
- KZR 03-25-2025
- Dividend Yield
- BDL 2.02%
- KZR N/A
- EPS Growth
- BDL N/A
- KZR N/A
- EPS
- BDL 1.78
- KZR N/A
- Revenue
- BDL $193,230,000.00
- KZR N/A
- Revenue This Year
- BDL N/A
- KZR N/A
- Revenue Next Year
- BDL N/A
- KZR N/A
- P/E Ratio
- BDL $13.91
- KZR N/A
- Revenue Growth
- BDL 8.87
- KZR N/A
- 52 Week Low
- BDL $23.94
- KZR $4.54
- 52 Week High
- BDL $29.72
- KZR $9.30
- Technical
- Relative Strength Index (RSI)
- BDL 46.24
- KZR 31.03
- Support Level
- BDL $24.47
- KZR $5.01
- Resistance Level
- BDL $25.50
- KZR $6.37
- Average True Range (ATR)
- BDL 0.38
- KZR 0.29
- MACD
- BDL -0.02
- KZR -0.09
- Stochastic Oscillator
- BDL 34.17
- KZR 0.00
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service and Package stores consist of retail liquor sales and related items. The company generates maximum revenue from Restaurant segment.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.